Literature DB >> 2936333

Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H.

J Alsenz, T F Schulz, J D Lambris, R B Sim, M P Dierich.   

Abstract

The action of six different enzymes on the function and structure of Factor H was investigated by use of sodium dodecyl sulphate/polyacrylamide-gel electrophoresis, haemagglutination, two enzyme-linked immunosorbent assay systems and an assay for Factor I cofactor activity. Six monoclonal antibodies directed against the 38 kDa tryptic fragment of Factor H [which contains the binding site for C3b (a 180 kDa fragment of the third component of complement) and the cofactor activity] were also used to detect cleavage products derived from the same fragment. Elastase, chymotrypsin A4 or trypsin first cleaved Factor H to 36-38 kDa fragments carrying all six monoclonal anti-(Factor H)-binding sites. In parallel, the interaction of Factor H with surface-bound C3b was lost, whereas the cofactor function was preserved. Further cleavage of the 36-38 kDa fragments into two 13-19 kDa fragments (one carrying the MAH4 and MRC OX 24 epitopes, the other the MAH1, MAH2, MAH3 and MRC OX 23 epitopes) destroyed cofactor activity. Pepsin, bromelain or papain rapidly split off a 13-15 kDa fragment of Factor H carrying the MAH1, MAH2, MAH3 and MRC OX 23 epitopes and destroyed all tested functions of Factor H. Ficin cleaved Factor H into disulphide-linked fragments smaller than 25 kDa, but did not affect the functions of the Factor H molecule. The 38 kDa tryptic fragment of Factor H is the N-terminal end of the Factor H molecule, as determined by N-terminal sequence analysis. A model is presented of the substructure of Factor H.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2936333      PMCID: PMC1152959          DOI: 10.1042/bj2320841

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  High-performance liquid chromatography of amino acid derivatives.

Authors:  C L Zimmerman; J J Pisano
Journal:  Methods Enzymol       Date:  1977       Impact factor: 1.600

2.  Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator.

Authors:  K Whaley; S Ruddy
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

3.  Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.

Authors:  M K Pangburn; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Control of the amplification convertase of complement by the plasma protein beta1H.

Authors:  J M Weiler; M R Daha; K F Austen; D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

7.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

8.  Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.

Authors:  M K Pangburn; R D Schreiber; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

9.  Modulation of the alternative complement pathways by beta 1 H globulin.

Authors:  K Whaley; S Ruddy
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

10.  ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

Authors:  U R NILSSON; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

View more
  27 in total

Review 1.  Immunopathological aspects of age-related macular degeneration.

Authors:  Mrinali Patel; Chi-Chao Chan
Journal:  Semin Immunopathol       Date:  2008-02-26       Impact factor: 9.623

Review 2.  Molecular pathology of age-related macular degeneration.

Authors:  Xiaoyan Ding; Mrinali Patel; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2008-11-06       Impact factor: 21.198

3.  Structural and functional analysis of CR2/EBV receptor by means of monoclonal antibodies and limited tryptic digestion.

Authors:  A L Petzer; T F Schulz; R Stauder; A Eigentler; B L Myones; M P Dierich
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

4.  Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55.

Authors:  Geoffrey Gifford; Vivian P Vu; Nirmal K Banda; V Michael Holers; Guankui Wang; Ernest V Groman; Donald Backos; Robert Scheinman; S Moein Moghimi; Dmitri Simberg
Journal:  J Control Release       Date:  2019-04-08       Impact factor: 9.776

5.  Interactions between human complement components factor H, factor I and C3b.

Authors:  C J Soames; R B Sim
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

6.  The complete amino acid sequence of human complement factor H.

Authors:  J Ripoche; A J Day; T J Harris; R B Sim
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

Review 7.  Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD).

Authors:  Hema L Ramkumar; Jun Zhang; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2010-03-03       Impact factor: 21.198

8.  Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies.

Authors:  Linda Mark; David G Proctor; David J Blackbourn; Anna M Blom; O Brad Spiller
Journal:  Immunology       Date:  2007-08-30       Impact factor: 7.397

9.  Pig complement regulator factor H: molecular cloning and functional characterization.

Authors:  Guido A Hegasy; Ute Willhoeft; Sandra A Majno; Harald Seeberger; Peter F Zipfel; Jens Hellwage
Journal:  Immunogenetics       Date:  2003-09-27       Impact factor: 2.846

10.  Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis.

Authors:  A K Sharma; M K Pangburn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.